Clinical trial
A Study of Adalimumab to Treat Sarcoidosis of the Skin
NCT00274352 · Pariser, Robert J., M.D., Other · Completed
Key facts
| NCT number | NCT00274352 |
|---|---|
| Title | A Study of Adalimumab to Treat Sarcoidosis of the Skin |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis |
| Lead sponsor | Pariser, Robert J., M.D., Other |
| Collaborators | Abbott Industry Virginia Clinical Research, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Drug |
| Interventions | adalimumab |
| Enrollment | 16 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Jan 10, 2006 |
| Last update posted | May 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: